{"hands_on_practices": [{"introduction": "The complement system is a powerful component of innate humoral immunity, capable of rapidly eliminating pathogens. However, this power must be tightly controlled to prevent damage to host tissues. This practice explores the principle of dynamic equilibrium by modeling the steady-state level of the C3 convertase enzyme, illustrating how its activity is kinetically balanced by constant formation and regulated decay. By analyzing the role of regulatory proteins like Factor H, you will gain a quantitative understanding of the homeostatic mechanisms that ensure the safety and efficacy of this first line of defense [@problem_id:5121440].", "problem": "A central enzyme complex of the alternative pathway of the complement system, the C3 convertase (C3bBb), is continuously formed on activating surfaces and decays spontaneously or under regulation by host proteins. Consider a well-mixed patch of an activating surface where the concentration of surface-bound convertase, denoted $C(t)$, evolves in time under the following experimentally supported assumptions: (i) formation proceeds at an approximately zero-order rate $k_f$ due to constant supply and properdin stabilization on the surface; (ii) decay is first-order with respect to $C(t)$ with a baseline rate constant $k_d$; and (iii) Complement Factor H (CFH) accelerates decay by binding to regulatory sites with dissociation constant $K_D$, so that the fractional occupancy is $\\theta = \\dfrac{[H]}{K_D + [H]}$, and the effective decay constant in the presence of CFH is $k_d^{\\mathrm{eff}} = k_d\\left(1 + \\alpha_{\\max}\\,\\theta\\right)$, where $\\alpha_{\\max}$ is the maximal fractional acceleration of decay at saturation.\n\nUse conservation of mass (formation minus loss) and first-order kinetics to derive the steady-state concentration $C^{\\ast}$ in terms of the parameters, and then compute its numerical value for the parameter set\n$k_f = 5.0\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$, $k_d = 0.50\\,\\mathrm{min}^{-1}$, $K_D = 50\\,\\mathrm{nM}$, $[H] = 50\\,\\mathrm{nM}$, and $\\alpha_{\\max} = 3.0$. Express the final steady-state convertase concentration in $\\mathrm{nM}$ and round your answer to four significant figures.", "solution": "The problem statement is evaluated for validity.\n\n### Step 1: Extract Givens\n-   System: C3 convertase (C3bBb) on an activating surface.\n-   Variable: $C(t)$, concentration of surface-bound convertase.\n-   Kinetic model assumptions:\n    -   (i) Formation is a zero-order process with rate $k_f$.\n    -   (ii) Decay is a first-order process with baseline rate constant $k_d$.\n    -   (iii) Complement Factor H (CFH) accelerates decay, with fractional occupancy $\\theta = \\dfrac{[H]}{K_D + [H]}$ and an effective decay constant $k_d^{\\mathrm{eff}} = k_d\\left(1 + \\alpha_{\\max}\\,\\theta\\right)$.\n-   Task: Derive the steady-state concentration $C^{\\ast}$ and compute its numerical value.\n-   Parameters:\n    -   $k_f = 5.0\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$\n    -   $k_d = 0.50\\,\\mathrm{min}^{-1}$\n    -   $K_D = 50\\,\\mathrm{nM}$\n    -   $[H] = 50\\,\\mathrm{nM}$\n    -   $\\alpha_{\\max} = 3.0$\n-   Output specifications: Express $C^{\\ast}$ in $\\mathrm{nM}$, rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem describes a simplified but standard kinetic model for the regulation of the alternative pathway C3 convertase, a fundamental component of the innate immune system. The model elements (zero-order formation, first-order decay, hyperbolic regulation by Factor H) are well-established principles in enzyme kinetics and immunology. All entities and their roles are correctly represented. The problem is scientifically sound.\n-   **Well-Posed**: The problem provides all necessary equations, parameters, and a clear objective (finding the steady-state concentration). The information is sufficient to determine a unique and meaningful solution.\n-   **Objective**: The language is precise, quantitative, and free of subjective or ambiguous terminology.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, contradiction, or being ill-posed. All provided parameters have consistent units.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution will be derived.\n\nThe evolution of the surface concentration of the C3 convertase, $C(t)$, is governed by the principle of mass conservation. The rate of change of $C(t)$ is equal to the rate of formation minus the rate of loss. Based on the provided assumptions, we can write the governing ordinary differential equation.\n\nThe rate of formation is given as a zero-order process with rate constant $k_f$.\n$$\n\\text{Rate of Formation} = k_f\n$$\nThe rate of decay is a first-order process with respect to the convertase concentration $C(t)$, but the rate constant is modulated by the concentration of Complement Factor H, $[H]$. The effective first-order rate constant is $k_d^{\\mathrm{eff}}$.\n$$\n\\text{Rate of Decay} = k_d^{\\mathrm{eff}} C(t)\n$$\nThe effective decay constant is given by the expression:\n$$\nk_d^{\\mathrm{eff}} = k_d\\left(1 + \\alpha_{\\max}\\,\\theta\\right)\n$$\nwhere $\\theta$ is the fractional occupancy of the regulatory sites by Factor H:\n$$\n\\theta = \\frac{[H]}{K_D + [H]}\n$$\nCombining these terms, the differential equation for the concentration $C(t)$ is:\n$$\n\\frac{dC(t)}{dt} = \\text{Rate of Formation} - \\text{Rate of Decay} = k_f - k_d^{\\mathrm{eff}} C(t)\n$$\nSubstituting the expression for $k_d^{\\mathrm{eff}}$, we have:\n$$\n\\frac{dC(t)}{dt} = k_f - k_d\\left(1 + \\alpha_{\\max} \\frac{[H]}{K_D + [H]}\\right) C(t)\n$$\nThe problem asks for the steady-state concentration, denoted as $C^{\\ast}$. At steady state, the concentration of the convertase is constant, which means its time derivative is zero.\n$$\n\\frac{dC}{dt} = 0\n$$\nSetting the differential equation to zero and replacing $C(t)$ with $C^{\\ast}$:\n$$\n0 = k_f - k_d\\left(1 + \\alpha_{\\max} \\frac{[H]}{K_D + [H]}\\right) C^{\\ast}\n$$\nWe can now solve for $C^{\\ast}$ by rearranging the equation:\n$$\nk_d\\left(1 + \\alpha_{\\max} \\frac{[H]}{K_D + [H]}\\right) C^{\\ast} = k_f\n$$\nIsolating $C^{\\ast}$ gives the general symbolic expression for the steady-state concentration:\n$$\nC^{\\ast} = \\frac{k_f}{k_d\\left(1 + \\alpha_{\\max} \\frac{[H]}{K_D + [H]}\\right)}\n$$\nNow, we substitute the provided numerical values into this expression:\n$k_f = 5.0\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$, $k_d = 0.50\\,\\mathrm{min}^{-1}$, $K_D = 50\\,\\mathrm{nM}$, $[H] = 50\\,\\mathrm{nM}$, and $\\alpha_{\\max} = 3.0$.\n\nFirst, we calculate the fractional occupancy, $\\theta$:\n$$\n\\theta = \\frac{50\\,\\mathrm{nM}}{50\\,\\mathrm{nM} + 50\\,\\mathrm{nM}} = \\frac{50}{100} = 0.5\n$$\nNext, we calculate the term in the parenthesis that represents the total acceleration of decay:\n$$\n1 + \\alpha_{\\max}\\,\\theta = 1 + (3.0)(0.5) = 1 + 1.5 = 2.5\n$$\nNow, we can calculate the full effective decay constant, $k_d^{\\mathrm{eff}}$:\n$$\nk_d^{\\mathrm{eff}} = k_d (2.5) = (0.50\\,\\mathrm{min}^{-1})(2.5) = 1.25\\,\\mathrm{min}^{-1}\n$$\nFinally, we compute the steady-state concentration $C^{\\ast}$ by dividing the formation rate by the effective decay rate:\n$$\nC^{\\ast} = \\frac{k_f}{k_d^{\\mathrm{eff}}} = \\frac{5.0\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}}{1.25\\,\\mathrm{min}^{-1}} = 4.0\\,\\mathrm{nM}\n$$\nThe problem requires the answer to be expressed in $\\mathrm{nM}$ and rounded to four significant figures. Therefore, the value $4.0\\,\\mathrm{nM}$ is written as $4.000\\,\\mathrm{nM}$.", "answer": "$$\\boxed{4.000}$$", "id": "5121440"}, {"introduction": "Beyond soluble factors, innate immunity relies on cellular sentinels like Natural Killer (NK) cells, which must make rapid life-or-death decisions about target cells. This exercise treats this process as a computational task, where the NK cell integrates signals from multiple activating and inhibitory receptors. You will build a quantitative model that translates receptor occupancy into a single decision variable, which in turn governs the probability of a cytotoxic response, providing insight into the logic of cellular decision-making [@problem_id:5121367].", "problem": "A Natural Killer (NK) cell integrates activating and inhibitory cues from a target cell to form a scalar decision variable that controls cytotoxic commitment. Assume the following biophysically grounded model components.\n\n1. Receptor occupancy follows the Langmuir isotherm under quasi-steady-state and ligand excess: for a cognate receptor–ligand pair with free ligand concentration $[L]$ and dissociation constant $K_d$, the fractional occupancy is $\\theta = \\dfrac{[L]}{[L] + K_d}$.\n\n2. The effective activating signal is a weighted sum of fractional occupancies from two distinct activating receptor–ligand pairs:\n$$\nA = w_1 \\,\\theta_1 + w_2 \\,\\theta_2,\n$$\nwhere $\\theta_j = \\dfrac{[L_j]}{[L_j] + K_{d,j}}$ for $j \\in \\{1,2\\}$ and $w_1, w_2 \\in (0,1)$ are dimensionless efficacy weights.\n\n3. The inhibitory signal arises from a single inhibitory receptor recognizing a major histocompatibility complex (MHC) class I ligand, modeled as\n$$\nI = w_I \\,\\theta_I,\\quad \\theta_I = \\dfrac{[H]}{[H] + K_{d,I}},\n$$\nwith $w_I \\in (0,1)$ a dimensionless inhibitory efficacy.\n\n4. The NK cell computes a dimensionless decision variable by subtraction:\n$$\nD = A - I.\n$$\n\n5. The probability of committing to cytotoxicity is mapped from $D$ by a Boltzmann-like sigmoid with slope parameter $\\alpha$ and activation midpoint $D_0$:\n$$\nP(D) = \\dfrac{1}{1 + \\exp\\!\\big(-\\alpha\\,(D - D_0)\\big)}.\n$$\n\nConsider a target cell displaying activating ligands with concentrations $[L_1] = 12\\,\\mathrm{nM}$, $[L_2] = 40\\,\\mathrm{nM}$ and an inhibitory MHC class I ligand with concentration $[H] = 100\\,\\mathrm{nM}$. The binding parameters are $K_{d,1} = 8\\,\\mathrm{nM}$, $K_{d,2} = 60\\,\\mathrm{nM}$, and $K_{d,I} = 25\\,\\mathrm{nM}$. The efficacy weights are $w_1 = 0.6$, $w_2 = 0.4$, and $w_I = 0.7$. The sigmoid parameters are $\\alpha = 7$ and $D_0 = 0.1$.\n\nUsing only the definitions above and the stated assumptions, compute the cytotoxic commitment probability $P$. Round your answer to four significant figures and express it as a unitless decimal (do not use a percentage sign).", "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n**Step 1: Extract Givens**\n- Fractional receptor occupancy, $\\theta$, for a ligand with concentration $[L]$ and dissociation constant $K_d$: $\\theta = \\dfrac{[L]}{[L] + K_d}$.\n- Effective activating signal, $A$: $A = w_1 \\,\\theta_1 + w_2 \\,\\theta_2$.\n- Fractional occupancy for activating receptors, $\\theta_j$: $\\theta_j = \\dfrac{[L_j]}{[L_j] + K_{d,j}}$ for $j \\in \\{1,2\\}$.\n- Efficacy weights for activating receptors: $w_1, w_2 \\in (0,1)$.\n- Inhibitory signal, $I$: $I = w_I \\,\\theta_I$.\n- Fractional occupancy for inhibitory receptor, $\\theta_I$: $\\theta_I = \\dfrac{[H]}{[H] + K_{d,I}}$.\n- Efficacy weight for inhibitory receptor: $w_I \\in (0,1)$.\n- Decision variable, $D$: $D = A - I$.\n- Cytotoxic commitment probability, $P(D)$: $P(D) = \\dfrac{1}{1 + \\exp(-\\alpha(D - D_0))}$.\n- Ligand concentrations: $[L_1] = 12\\,\\mathrm{nM}$, $[L_2] = 40\\,\\mathrm{nM}$, $[H] = 100\\,\\mathrm{nM}$.\n- Dissociation constants: $K_{d,1} = 8\\,\\mathrm{nM}$, $K_{d,2} = 60\\,\\mathrm{nM}$, $K_{d,I} = 25\\,\\mathrm{nM}$.\n- Efficacy weights: $w_1 = 0.6$, $w_2 = 0.4$, $w_I = 0.7$.\n- Sigmoid parameters: $\\alpha = 7$, $D_0 = 0.1$.\n- Required task: Compute $P$ and round to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed as valid based on the following criteria:\n- **Scientifically Grounded**: The model components (Langmuir isotherm, weighted signal integration, sigmoidal decision function) are standard biophysical and computational biology formalisms for modeling cellular signaling and decision-making. The context of Natural Killer cell activation is appropriate and the parameters are within plausible physiological ranges.\n- **Well-Posed**: All necessary variables, constants, and equations required to compute the final probability are explicitly provided. The problem is self-contained and mathematically structured to yield a unique solution.\n- **Objective**: The problem is stated using precise, formal, and unbiased language. There are no subjective or ambiguous terms.\n- **Consistency**: The units for ligand concentrations and dissociation constants are consistent (nM), ensuring that the fractional occupancies are correctly calculated as dimensionless quantities. All subsequent variables ($A$, $I$, $D$) are also dimensionless, as required by the argument of the exponential function in the probability formula.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A step-by-step solution will be provided.\n\nThe calculation proceeds by sequentially determining the value of each variable in the model.\n\nFirst, we compute the fractional occupancies for the two activating receptors, $\\theta_1$ and $\\theta_2$.\nFor the first activating receptor:\n$$\n\\theta_1 = \\dfrac{[L_1]}{[L_1] + K_{d,1}} = \\dfrac{12\\,\\mathrm{nM}}{12\\,\\mathrm{nM} + 8\\,\\mathrm{nM}} = \\dfrac{12}{20} = 0.6\n$$\nFor the second activating receptor:\n$$\n\\theta_2 = \\dfrac{[L_2]}{[L_2] + K_{d,2}} = \\dfrac{40\\,\\mathrm{nM}}{40\\,\\mathrm{nM} + 60\\,\\mathrm{nM}} = \\dfrac{40}{100} = 0.4\n$$\n\nNext, we compute the total effective activating signal, $A$, using the given efficacy weights $w_1 = 0.6$ and $w_2 = 0.4$:\n$$\nA = w_1 \\theta_1 + w_2 \\theta_2 = (0.6)(0.6) + (0.4)(0.4) = 0.36 + 0.16 = 0.52\n$$\n\nNow, we compute the fractional occupancy for the single inhibitory receptor, $\\theta_I$:\n$$\n\\theta_I = \\dfrac{[H]}{[H] + K_{d,I}} = \\dfrac{100\\,\\mathrm{nM}}{100\\,\\mathrm{nM} + 25\\,\\mathrm{nM}} = \\dfrac{100}{125} = \\dfrac{4}{5} = 0.8\n$$\n\nWe then compute the total inhibitory signal, $I$, using the inhibitory efficacy weight $w_I = 0.7$:\n$$\nI = w_I \\theta_I = (0.7)(0.8) = 0.56\n$$\n\nWith both activating and inhibitory signals calculated, we can determine the decision variable, $D$, by subtraction:\n$$\nD = A - I = 0.52 - 0.56 = -0.04\n$$\n\nFinally, we compute the probability of cytotoxic commitment, $P(D)$, using the given sigmoid parameters $\\alpha = 7$ and $D_0 = 0.1$:\n$$\nP(D) = \\dfrac{1}{1 + \\exp(-\\alpha(D - D_0))}\n$$\nSubstituting the values:\n$$\nP = \\dfrac{1}{1 + \\exp(-7(-0.04 - 0.1))} = \\dfrac{1}{1 + \\exp(-7(-0.14))} = \\dfrac{1}{1 + \\exp(0.98)}\n$$\nTo obtain a numerical value, we evaluate the exponential term:\n$$\n\\exp(0.98) \\approx 2.664456\n$$\nTherefore, the probability is:\n$$\nP \\approx \\dfrac{1}{1 + 2.664456} = \\dfrac{1}{3.664456} \\approx 0.272895\n$$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $2$, $7$, $2$, and $8$. The fifth digit is $9$, so we round up the fourth digit.\n$$\nP \\approx 0.2729\n$$\nThis is the final, unitless decimal probability.", "answer": "$$\\boxed{0.2729}$$", "id": "5121367"}, {"introduction": "A key architectural feature of the immune system is the division between the immediate innate response and the delayed but highly specific adaptive response. This practice focuses on the kinetics that govern this delay by modeling the clonal expansion of an antigen-specific T cell population from a small number of precursors. By calculating the time required to generate a functionally sufficient number of effector cells, you will quantify the critical window during which innate mechanisms must control an infection, highlighting a fundamental temporal trade-off in immunity [@problem_id:5121384].", "problem": "An acute RNA virus infection is sampled longitudinally in a patient enrolled in a translational study of immune system architecture and functional divisions. Molecular quantification using Quantitative Polymerase Chain Reaction (qPCR) and flow cytometry identifies an antigen-specific cluster of differentiation 8 (CD8) T cell response. From a peripheral blood mononuclear cell (PBMC) compartment adjusted to whole-body estimates, the initial antigen-specific clone size is measured as $N_{0} = 7.5 \\times 10^{5}$ cells at the time of symptom onset. Independent proliferation assays combining deuterium labeling and Ki-67 immunostaining estimate a constant per-capita clonal expansion rate $r = 0.90 \\ \\text{day}^{-1}$ during the early response phase. Based on prior clinical modeling of effector-mediated viral control (including Type I Interferon (IFN-I) priming and Natural Killer (NK) cell bridge functions), the functional threshold for adaptive effector CD8 T cells is $N^{\\ast} = 2.0 \\times 10^{9}$ cells, beyond which viremia begins a sustained decline measurable by qPCR.\n\nStarting only from the definition that early-phase clonal expansion is well approximated by exponential growth with constant per-capita rate and initial condition, derive the time $t$ required for the adaptive effector population to reach $N^{\\ast}$. Then, compute $t$ using the given parameters. Round your final numerical result to four significant figures and express time in days. Briefly interpret, in principle, how this $t$ defines the clinical window during which innate mechanisms must maintain control prior to adaptive dominance; your interpretation should be conceptual and require no additional computation.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in quantitative immunology, well-posed with a complete and consistent set of parameters, and presented objectively. The problem requires the derivation and calculation of the time needed for an antigen-specific T cell population to expand to a functional threshold, based on a standard exponential growth model.\n\nThe problem states that the early-phase clonal expansion of the antigen-specific CD8 T cell population, $N(t)$, is well approximated by exponential growth with a constant per-capita rate, $r$. This process can be described by the following first-order linear ordinary differential equation:\n$$\n\\frac{dN}{dt} = rN\n$$\nHere, $N(t)$ is the number of cells at time $t$, and $r$ is the per-capita clonal expansion rate. The initial condition is given as the clone size at the time of symptom onset ($t=0$), which is $N(0) = N_0$.\n\nTo find the function $N(t)$, we solve this differential equation by separation of variables:\n$$\n\\frac{dN}{N} = r \\, dt\n$$\nWe integrate both sides from the initial state $(t=0, N=N_0)$ to a later state $(t, N(t))$:\n$$\n\\int_{N_0}^{N(t)} \\frac{1}{N'} \\, dN' = \\int_{0}^{t} r \\, dt'\n$$\nThe integration yields:\n$$\n[\\ln|N'|]_{N_0}^{N(t)} = [r t']_{0}^{t}\n$$\nSince the cell population $N$ is always positive, the absolute value is redundant.\n$$\n\\ln(N(t)) - \\ln(N_0) = r(t - 0)\n$$\nUsing the properties of logarithms, we can write:\n$$\n\\ln\\left(\\frac{N(t)}{N_0}\\right) = rt\n$$\nTo solve for $N(t)$, we exponentiate both sides:\n$$\n\\frac{N(t)}{N_0} = \\exp(rt)\n$$\n$$\nN(t) = N_0 \\exp(rt)\n$$\nThis is the standard equation for exponential growth, describing the size of the T cell population at any given time $t$ during the expansion phase.\n\nThe problem asks for the time $t$ required for this population to reach the functional threshold for adaptive effector cells, denoted as $N^{\\ast}$. We set $N(t) = N^{\\ast}$ and solve for $t$:\n$$\nN^{\\ast} = N_0 \\exp(rt)\n$$\nTo isolate $t$, we first divide by $N_0$:\n$$\n\\frac{N^{\\ast}}{N_0} = \\exp(rt)\n$$\nNext, we take the natural logarithm of both sides:\n$$\n\\ln\\left(\\frac{N^{\\ast}}{N_0}\\right) = \\ln(\\exp(rt))\n$$\n$$\n\\ln\\left(\\frac{N^{\\ast}}{N_0}\\right) = rt\n$$\nFinally, we solve for $t$:\n$$\nt = \\frac{1}{r} \\ln\\left(\\frac{N^{\\ast}}{N_0}\\right)\n$$\nThis is the derived analytical expression for the time required to reach the threshold.\n\nNow, we compute the numerical value for $t$ using the given parameters:\n- Initial antigen-specific clone size: $N_0 = 7.5 \\times 10^{5}$ cells\n- Per-capita clonal expansion rate: $r = 0.90 \\ \\text{day}^{-1}$\n- Functional threshold for effector cells: $N^{\\ast} = 2.0 \\times 10^{9}$ cells\n\nSubstituting these values into the derived expression for $t$:\n$$\nt = \\frac{1}{0.90} \\ln\\left(\\frac{2.0 \\times 10^{9}}{7.5 \\times 10^{5}}\\right)\n$$\nFirst, we compute the ratio inside the logarithm:\n$$\n\\frac{N^{\\ast}}{N_0} = \\frac{2.0 \\times 10^{9}}{7.5 \\times 10^{5}} = \\frac{2.0}{7.5} \\times 10^{9-5} = \\frac{20}{75} \\times 10^{4} = \\frac{4}{15} \\times 10^{4} = \\frac{40000}{15} = \\frac{8000}{3}\n$$\nThe value of the ratio is approximately $2666.67$. Now, we calculate $t$:\n$$\nt = \\frac{1}{0.90} \\ln\\left(\\frac{8000}{3}\\right)\n$$\nUsing computational tools for the natural logarithm:\n$$\n\\ln\\left(\\frac{8000}{3}\\right) \\approx 7.888583\n$$\nTherefore:\n$$\nt \\approx \\frac{7.888583}{0.90} \\approx 8.765092 \\ \\text{days}\n$$\nThe problem requires rounding the final result to four significant figures.\n$$\nt \\approx 8.765 \\ \\text{days}\n$$\n\nFor the conceptual interpretation, this calculated time $t \\approx 8.765$ days represents the intrinsic kinetic delay of the primary adaptive immune response. It is the period after symptom onset during which the antigen-specific CD8 T cell population must undergo massive proliferation to reach a sufficient size to exert effective control over the viral pathogen. During this critical window, the host's defense relies on the innate immune system (e.g., NK cells, macrophages, and the effects of cytokines like Type I interferons). The innate response must contain the pathogen and limit its spread to prevent overwhelming infection and pathology before the more potent and specific adaptive T cell response becomes dominant at time $t$. This time lag is a fundamental trade-off in immunity, balancing the need for specificity with the time required to generate an effective number of effector cells from a very small pool of initial precursors.", "answer": "$$\n\\boxed{8.765}\n$$", "id": "5121384"}]}